HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CENPW
centromere protein W
Chromosome 6 · 6q22.32
NCBI Gene: 387103Ensembl: ENSG00000203760.10HGNC: HGNC:21488UniProt: A0A0A0MRK5
53PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
chromosome, centromeric regionkinetochorenucleoplasmprotein bindingneurodegenerative diseasetype 2 diabetes mellitusAbnormality of the skeletal systemcoronary artery disease
✦AI Summary

CENPW (centromere protein W) is a centromeric protein essential for kinetochore assembly and chromosome 6. As a component of the CENP-T-W-S-X heterotetrameric complex, CENPW binds and supercoils DNA, playing a fundamental role in kinetochore assembly and mitotic progression [UniProt annotation]. The protein is part of the CENPA-NAC complex involved in recruiting CENPA-CAD complexes and incorporating newly synthesized CENPA into centromeres. Clinically, CENPW overexpression is associated with poor prognosis in hepatocellular carcinoma (HCC), where elevated CENPW levels correlate with unfavorable outcomes 1. CENPW knockdown in HCC cells inhibits proliferation, migration, and invasion while inducing G2/M phase arrest and apoptosis, potentially through E2F signaling inactivation 2. Similarly, in clear cell renal cell carcinoma (ccRCC), elevated CENPW expression associates with reduced overall survival and is recognized as an independent negative prognostic factor 3. CENPW silencing in KIRC inhibits cell proliferation, migration, and invasion while increasing PD-L1 and E-cadherin expression, implicating roles in immune responses and epithelial-mesenchymal transition 4. CENPW was identified as a hub biomarker in HCC diagnostic prediction models 5 and as one of eight immune evasion-related genes prognostic for immunotherapy response in ccRCC 6. Additionally, CENPW variants associate with liver volume and skeletal muscle phenotypes, with sex-specific metabolic effects 7.

Sources cited
1
CENPW is overexpressed in HCC tissues; low CENPW expression correlates with better prognosis; knockdown inhibits proliferation, migration, invasion and induces apoptosis and G2/M arrest
PMID: 32635817
2
CENPW knockdown in HCC inhibits proliferation, migration, invasion and induces G0/G1 arrest and apoptosis through E2F signaling regulation
PMID: 33973496
3
Elevated CENP-W expression significantly associates with poorer overall survival in ccRCC; confirmed as independent negative prognostic factor; involved in immune-related pathways and lipid metabolism
PMID: 40531390
4
CENPW is markedly elevated in KIRC; silencing inhibits proliferation, migration, invasion, and tumor growth; increases PD-L1 and E-cadherin expression; associated with therapeutic sensitivity
PMID: 41077212
5
CENPW identified as hub biomarker in HCC through machine learning analysis for diagnostic prediction
PMID: 40169794
6
CENPW is one of eight immune evasion-related genes significantly associated with immunotherapy prognosis in ccRCC
PMID: 39288623
7
CENPW variants associate with liver volume increase and higher skeletal muscle volumes with sex-specific effects
PMID: 40823175
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.53Moderate
type 2 diabetes mellitusOpen Targets
0.49Moderate
Abnormality of the skeletal systemOpen Targets
0.47Moderate
coronary artery diseaseOpen Targets
0.44Moderate
type 1 diabetes mellitusOpen Targets
0.42Moderate
androgenetic alopeciaOpen Targets
0.38Weak
mathematical abilityOpen Targets
0.37Weak
attention deficit hyperactivity disorderOpen Targets
0.37Weak
obesityOpen Targets
0.36Weak
Abnormal urine sodium concentrationOpen Targets
0.34Weak
CraniopharyngiomaOpen Targets
0.34Weak
schizophreniaOpen Targets
0.34Weak
alcohol abuseOpen Targets
0.33Weak
alcohol-induced disordersOpen Targets
0.32Weak
diabetes mellitusOpen Targets
0.32Weak
overnutritionOpen Targets
0.31Weak
adolescent idiopathic scoliosisOpen Targets
0.29Weak
intelligenceOpen Targets
0.29Weak
squamous cell carcinomaOpen Targets
0.28Weak
Abruptio PlacentaeOpen Targets
0.28Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CENPBProtein interaction100%TRAProtein interaction100%OIP5Protein interaction100%CENPQProtein interaction100%KNL1Protein interaction100%CENPMProtein interaction100%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
30%
Lung
9%
Ovary
7%
Liver
5%
Heart
1%
Gene Interaction Network
Click a node to explore
CENPWCENPBTRAOIP5CENPQKNL1CENPM
PROTEIN STRUCTURE
Preparing viewer…
PDB7R5S · 2.83 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.55Moderately Constrained
pLIⓘ
0.88Intermediate
Observed/Expected LoF0.00 [0.00–0.55]
RankingsWhere CENPW stands among ~20K protein-coding genes
  • #8,406of 20,598
    Most Researched53
  • #3,530of 17,882
    Most Constrained (LOEUF)0.55 · top quartile
Genes detectedCENPW
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Integrating single-cell RNA sequencing, WGCNA, and machine learning to identify key biomarkers in hepatocellular carcinoma.
PMID: 40169794
Sci Rep · 2025
1.00
2
Histone-fold centromere protein W (CENP-W) is associated with the biological behavior of hepatocellular carcinoma cells.
PMID: 32635817
Bioengineered · 2020
0.90
3
Association and shared biological bases between birth weight and cortical structure.
PMID: 40044659
Transl Psychiatry · 2025
0.80
4
Integrative multi-omics analysis and experimental validation reveal centromere protein W as a potential therapeutic target and predictive biomarker in renal clear cell carcinoma.
PMID: 41077212
Int J Biol Macromol · 2025
0.70
5
Identification of CENPW as a prognostic biomarker and potential therapeutic target for clear cell renal cell carcinoma.
PMID: 40531390
Discov Oncol · 2025
0.60